| 产品描述: | TC-2153 is a selective inhibitor of striatal-enriched protein tyrosine phosphatase (STEP), with psychotropic activity and low acute toxicity. TC-2153 increases the expression of brain-derived neurotropic factor (BDNF) in the brain. And it decreases MAOA and 5-HT1A receptors mRNA level in midbrain. TC-2153 also inhibits 5-HT2A receptor-mediated signaling. |
| 靶点: |
5-HT1A Receptor;5-HT2A Receptor;MAO-A |
| 体外研究: |
Chronic TC-2153 treatment: TC-2153 (20 mg/kg; i.p.; once daily for 7 d) shows antidepressant-like effect without altering locomotor, exploratory activity and anxiety[1]. Acute TC-2153 treatment: TC-2153 (10 mg/kg and 20 mg/kg; p.o.; single dose) inhibits the functional activity of 5-HT2A receptors in vivo in mice[1]. |
| 体内研究: |
TC-2153 (10 μM; 3 h) decreases the percentage of DOI hydrochloride.html" class="link-product" target="_blank">DOI -induced c-fos positive neurons in cortical and hippocampal neurons cultured in vitro. |
| 保存条件: |
-80°C 6个月; -20°C 1个月, 干燥 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.81 ml |
14.049 ml |
28.099 ml |
| 5 mM |
0.562 ml |
2.81 ml |
5.62 ml |
| 10 mM |
0.281 ml |
1.405 ml |
2.81 ml |
| 50 mM |
0.056 ml |
0.281 ml |
0.562 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |